The role of autologous transplantation in patients with multiple myeloma aged 65 years and over (Q28373004)

2

0 references

J Treleaven

3

0 references

P Mainwaring

4

0 references

S Kulkarni

5

0 references

H Pandha

6

0 references

N Bhagwati

7

0 references

C Horton

8

0 references

S Singhal

9

0 references

J Mehta

Bone Marrow Transplantation

10

0 references

language of work or name

English

0 references

publication date

March 2000

0 references

published in

0 references

volume

25

0 references

issue

5

0 references

page(s)

533-9

0 references

cites work

High-dose melphalan for multiple myeloma: long-term follow-up data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

Regulation of initial vinblastine influx by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

A cellulose acetate immunofixation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

Use of Ranks in One-Criterion Variance Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

Analysis of prospective epidemiologic studies by minimum distance case-control matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

7 January 2021

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

7 January 2021

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

7 January 2021

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

7 January 2021

Intensive treatment of multiple myeloma and criteria for complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

7 January 2021

Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702188

7 January 2021